Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001600620-24-000114

Director sold 5,241 shares at $8.43 ($44,182)

  • Director acquired 17,913 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Smith Karen L. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-08 Exercise or conversion : show line 1 in the form +17,913 17,913 D
2024-11-11 Sale : show line 2 in the form −5,241 $8.43 $44,182 12,672 D
Open-market sales · 5,241 sh · avg $8.43 · $44,182

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-08 Exercise or conversion : show line 3 in the form Restricted Stock Units −17,913 0 D
Loading xslF345X05/wk-form4_1731457229.xml…